Dr. Samuel Funt, MD

Claim this profile

Memorial Sloan Kettering Bergen

Studies Uterine Tumors
Studies Transitional Cell Carcinoma
4 reported clinical trials
9 drugs studied

Area of expertise

1Uterine Tumors
Samuel Funt, MD has run 2 trials for Uterine Tumors. Some of their research focus areas include:
Stage IV
2Transitional Cell Carcinoma
Samuel Funt, MD has run 2 trials for Transitional Cell Carcinoma. Some of their research focus areas include:
Stage IV
Stage III

Affiliated Hospitals

Image of trial facility.
Memorial Sloan Kettering Bergen
Image of trial facility.
Memorial Sloan Kettering Cancer Center (All Protocol Activities)

Clinical Trials Samuel Funt, MD is currently running

Image of trial facility.

Immunotherapy + Targeted Therapy

for Genitourinary Cancers

This phase II trial studies how well cabozantinib works in combination with nivolumab and ipilimumab in treating patients with rare genitourinary (GU) tumors that has spread from where it first started (primary site) to other places in the body. Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving cabozantinib, nivolumab, and ipilimumab may work better in treating patients with genitourinary tumors that have no treatment options compared to giving cabozantinib, nivolumab, or ipilimumab alone.
Recruiting1 award Phase 221 criteria

More about Samuel Funt, MD

Clinical Trial Related8 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Samuel Funt, MD has experience with
  • Durvalumab, Tremelimumab
  • Atezolizumab
  • Cisplatin
  • Gemcitabine
  • Durvalumab
  • Radiation Therapy
Breakdown of trials Samuel Funt, MD has run
Uterine Tumors
Transitional Cell Carcinoma
Bladder Cancer
Lung Cancer
Ovarian Germ Cell Tumor

Other Doctors you might be interested in

Urvi Shah, MDMemorial Sloan Kettering Nassau (All Protocol Activities)
Roni Tamari, MDMemorial Sloan Kettering Cancer Center
Shari Goldfarb, MDMemorial Sloan Kettering Cancer Center

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Samuel Funt, MD specialize in?
Samuel Funt, MD focuses on Uterine Tumors and Transitional Cell Carcinoma. In particular, much of their work with Uterine Tumors has involved Stage IV patients, or patients who are undergoing treatment.
Is Samuel Funt, MD currently recruiting for clinical trials?
Yes, Samuel Funt, MD is currently recruiting for 1 clinical trial in Montvale New Jersey. If you're interested in participating, you should apply.
Are there any treatments that Samuel Funt, MD has studied deeply?
Yes, Samuel Funt, MD has studied treatments such as Durvalumab, Tremelimumab, Atezolizumab, Cisplatin.
What is the best way to schedule an appointment with Samuel Funt, MD?
Apply for one of the trials that Samuel Funt, MD is conducting.
What is the office address of Samuel Funt, MD?
The office of Samuel Funt, MD is located at: Memorial Sloan Kettering Bergen, Montvale, New Jersey 07645 United States. This is the address for their practice at the Memorial Sloan Kettering Bergen.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top